Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue and exhaustion are among the most commonly reported side effects of Mounjaro (tirzepatide), particularly in the first weeks of treatment or after a dose increase. Clinical trials recorded tiredness in a meaningful proportion of participants, and the NHS lists fatigue explicitly as a known side effect. It does not mean the treatment has failed, but it does warrant attention. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed over 2,500 adults with obesity across 72 weeks of tirzepatide treatment. Fatigue appeared in the reported side-effect data alongside the more commonly discussed gastrointestinal complaints. That pattern held across the broader SURMOUNT programme. The NHS tirzepatide medicines page lists tiredness as a known side effect and recommends telling your doctor or pharmacist if it becomes troublesome. None of this means exhaustion is inevitable, but it is common enough that dismissing it as coincidence is usually wrong.
The timing is telling. Reports of tirzepatide exhaustion cluster around two points: the first two to three weeks of treatment, when the body is adjusting to a drug that slows gastric emptying and significantly blunts appetite, and the days after a dose increase, when the same adjustment repeats at a higher intensity. If you want a closer look at what this pattern involves, our page on feeling exhausted on Mounjaro covers the experience in detail. A smaller group finds it lingers, which is worth discussing with a prescriber before attributing it to something else entirely.
One practical note: Mounjaro arrives in a discreet box from DPD, and the pen itself needs to live in the fridge. Some people find it helpful to inject on the same evening each week so the dose timing becomes routine — consistency seems to help people track how their energy shifts across the week.
Several mechanisms are thought to overlap. First, the appetite suppression that makes tirzepatide effective also means many people eat considerably less than they did before. A sharp drop in calorie intake, especially if protein intake falls with it, leaves the body running on reduced fuel. Muscles feel heavy, concentration slips, and the urge to rest increases. This is not a sign the medicine is working too hard; it is usually a sign that the diet adjustment needs some attention.
Second, gastrointestinal side effects (nausea, loose stools, or repeated vomiting) can quietly cause mild dehydration. Even mild fluid loss amplifies fatigue significantly. People who are managing digestive discomfort alongside their treatment are particularly vulnerable to this cycle. Drinking water consistently throughout the day, rather than catching up in the evening, tends to help more than people expect.
Third, the GIP and GLP-1 receptor pathways that tirzepatide activates influence more than appetite. They play roles in energy regulation and sleep quality, and some people notice disrupted sleep, particularly in early treatment. Poor sleep compounds any daytime tiredness and can make a manageable side effect feel far worse. If sleep disruption is prominent, it is worth mentioning separately to your prescriber, as it is a distinct pattern from straightforward fatigue.
The steps that reliably reduce fatigue on tirzepatide are less dramatic than people sometimes hope. Adequate protein (roughly 1.2–1.6 g per kilogram of body weight per day, though your prescriber or a dietitian can personalise this) helps preserve muscle and supports energy. Eating small, frequent meals is often easier on a stomach that empties slowly, and it keeps blood glucose steadier than skipping meals and then eating a large one. Resistance exercise, even light bodyweight work, supports both energy levels and muscle retention during weight loss; the NHS Better Health programme offers practical starting points.
Hydration is worth repeating. A litre and a half to two litres of water across the day is a reasonable baseline for most adults, more if the weather is warm or GI symptoms are active. Alcohol tends to worsen fatigue and interacts poorly with the GI side-effect profile, so many people find reducing it makes a meaningful difference early in treatment.
If you are wondering about the cost picture around ongoing treatment, our Mounjaro pricing page explains what a transparent private service includes. For questions specific to your situation, the broader guide to common Mounjaro questions covers a range of what people ask most.
Most fatigue on tirzepatide is self-limiting and responds to the practical measures above. There are situations, though, where it signals something that needs clinical input rather than self-management. Exhaustion that is severe, that comes on suddenly, or that is accompanied by other symptoms (significant abdominal pain, yellowing of the skin, rapid heart rate, or feeling faint when standing) needs prompt attention. These patterns may point to complications unrelated to the adjustment period.
If fatigue has not improved after two to three weeks at a stable dose, our guide for people who find themselves exhausted on Mounjaro may help you decide whether to seek further clinical input. It may be that the dose is moving too quickly for your system, that something else is going on clinically, or simply that your prescriber can offer reassurance having reviewed the full picture. Mounjaro's licensed titration schedule exists partly for this reason, giving the body time to adapt before the dose increases. You can read more about how tirzepatide works and what the titration schedule involves.
You should never feel you are managing Mounjaro side effects alone. Our prescribers offer seven-day aftercare, and if your energy levels are a concern, speaking to the clinical team is always the right first move. If you have not yet started treatment and are weighing up your options, our weight-loss treatment overview sets out how the process works from the beginning. To speak to our prescribers directly, start your free consultation and they will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.